Australia's largest stock trading and investment forum Australia's #1 stock forum

DLM

Click for more information

0.00%

3.2¢ dominion minerals limited

Value, page-21

First 21 Last

Share
Profile

Follow
Eagleeye8

7 Posts.

07/11/18

00:58

Post #: 36410835
Share

Originally posted by writer: ↑

Very funny, Flotsam.

I spent a couple of hours on Sunday objectively going over every announcement since relist. I looked at it from the perspective of a potential investor who knew nothing about TIS or the re-birthed FTT. Would I invest? For me, the answer was yes. I did not see anything to suggest the results will be anything other than what the trial was specifically designed to achieve. That is not the same thing as saying there was, or is nothing.

Right from the outset there has been a common thread of quiet confidence in the work being done. As the trial has progressed, that confidence has only increased, evidenced not only by the quality of the information released, but more recently with regard to how the company is preparing for business post-readout.

That's just my take on it. Don't know if I have mentioned it before, but I also held TIS, very small in comparison, but costly nonetheless. I have learned a lot since then. At least, I hope I have. My postion now is one of looking forward to Factor Therapeutics taking its place as an all too rare Australian biotech success story.

If I'm wrong...nah, not even going to go there.

Expand

Originally posted by writer: ↑

Very funny, Flotsam.

I spent a couple of hours on Sunday objectively going over every announcement since relist. I looked at it from the perspective of a potential investor who knew nothing about TIS or the re-birthed FTT. Would I invest? For me, the answer was yes. I did not see anything to suggest the results will be anything other than what the trial was specifically designed to achieve. That is not the same thing as saying there was, or is nothing.

Right from the outset there has been a common thread of quiet confidence in the work being done. As the trial has progressed, that confidence has only increased, evidenced not only by the quality of the information released, but more recently with regard to how the company is preparing for business post-readout.

That's just my take on it. Don't know if I have mentioned it before, but I also held TIS, very small in comparison, but costly nonetheless. I have learned a lot since then. At least, I hope I have. My postion now is one of looking forward to Factor Therapeutics taking its place as an all too rare Australian biotech success story.

If I'm wrong...nah, not even going to go there.

Expand

Originally posted by writer: ↑

Very funny, Flotsam.

I spent a couple of hours on Sunday objectively going over every announcement since relist. I looked at it from the perspective of a potential investor who knew nothing about TIS or the re-birthed FTT. Would I invest? For me, the answer was yes. I did not see anything to suggest the results will be anything other than what the trial was specifically designed to achieve. That is not the same thing as saying there was, or is nothing.

Right from the outset there has been a common thread of quiet confidence in the work being done. As the trial has progressed, that confidence has only increased, evidenced not only by the quality of the information released, but more recently with regard to how the company is preparing for business post-readout.

That's just my take on it. Don't know if I have mentioned it before, but I also held TIS, very small in comparison, but costly nonetheless. I have learned a lot since then. At least, I hope I have. My postion now is one of looking forward to Factor Therapeutics taking its place as an all too rare Australian biotech success story.

If I'm wrong...nah, not even going to go there.

Expand

FTT Price at posting: 7.1¢ Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

Trump is President Again: What Does This Mean for Crypto?

3DA

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

MEU

Marmota hits titanium from surface downhole 4 targets at Muckanippie

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

CBA

CBA says profits steady in first quarter of FY25, eyeing slow inflation moderation

There are more pages in this discussion • 41 more messages in this thread...

First 21 Last

Add DLM (ASX) to my watchlist